Cargando…
Herpesviridae systemic reactivation in patients with COVID-19-associated ARDS
Autores principales: | Reizine, F., Liard, C., Pronier, C., Thibault, V., Maamar, A., Gacouin, A., Tadié, J.-M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Healthcare Infection Society. Published by Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8596658/ https://www.ncbi.nlm.nih.gov/pubmed/34800612 http://dx.doi.org/10.1016/j.jhin.2021.11.007 |
Ejemplares similares
-
Herpesviridae reactivation for poor outcome in ARDS patients with ECMO: criminal or witness?
por: Huang, Huixue, et al.
Publicado: (2020) -
Response to Huang et al. “Herpesviridae reactivation for poor outcome in ARDS patients with ECMO: criminal or witness?”
por: Hraiech, Sami, et al.
Publicado: (2020) -
Herpes simplex virus and cytomegalovirus reactivations among severe COVID-19 patients
por: Le Balc’h, Pierre, et al.
Publicado: (2020) -
Short-term survival of acute respiratory distress syndrome patients due to influenza virus infection alone: a cohort study
por: Gacouin, Arnaud, et al.
Publicado: (2020) -
Acquired agitation in acute respiratory distress syndrome with COVID-19 compared to influenza patients: a propensity score matching observational study
por: Maamar, Adel, et al.
Publicado: (2022)